First Time Loading...
Z

Zymergen Inc
NASDAQ:ZY

Watchlist Manager
Zymergen Inc
NASDAQ:ZY
Watchlist
Price: 2.43 USD Market Closed
Updated: Mar 29, 2024

Intrinsic Value

ZY price has not been updated for more than 3 months. This may indicate that the stock has been delisted.

Zymergen, Inc. engages in the design, development, and commercialization of bio-based products. [ Read More ]

There is not enough data to reliably calculate the intrinsic value of ZY.

Key Points:
ZY Intrinsic Value
Base Case
Not Available
Z
Base Case Scenario

Fundamental Analysis

How can I assist you today?

Provide an overview
of Zymergen Inc's business.

What risks and challenges
does Zymergen Inc face in the near future?

Summarize the latest earnings report
of Zymergen Inc.

Provide P/E
for Zymergen Inc and its competitors.

Financials

Balance Sheet Decomposition
Zymergen Inc

Current Assets 239.6m
Cash & Short-Term Investments 213.6m
Receivables 3.7m
Other Current Assets 22.4m
Non-Current Assets 231.3m
PP&E 211.7m
Intangibles 7.4m
Other Non-Current Assets 12.3m
Current Liabilities 52.2m
Accounts Payable 12.9m
Accrued Liabilities 34.9m
Other Current Liabilities 4.4m
Non-Current Liabilities 182.1m
Other Non-Current Liabilities 182.1m
Efficiency

Earnings Waterfall
Zymergen Inc

Revenue
14.5m USD
Cost of Revenue
-48.9m USD
Gross Profit
-34.4m USD
Operating Expenses
-232.8m USD
Operating Income
-267.2m USD
Other Expenses
-97.8m USD
Net Income
-365m USD

Free Cash Flow Analysis
Zymergen Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

ZY Profitability Score
Profitability Due Diligence

Zymergen Inc's profitability score is 14/100. The higher the profitability score, the more profitable the company is.

Negative 1-Year Revenue Growth
Negative Operating Income
Negative Net Income
Negative ROE
14/100
Profitability
Score

Zymergen Inc's profitability score is 14/100. The higher the profitability score, the more profitable the company is.

ZY Solvency Score
Solvency Due Diligence

Zymergen Inc's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Low Altman Z-Score
45/100
Solvency
Score

Zymergen Inc's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ZY Price Targets Summary
Zymergen Inc

There are no price targets for ZY.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

ZY Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

ZY Price
Zymergen Inc

1M 1M
-
6M 6M
-
1Y 1Y
-
3Y 3Y
-94%
5Y 5Y
-94%
10Y 10Y
-94%
Annual Price Range
2.43
52w Low
N/A
52w High
N/A
Price Metrics
Average Annual Return
N/A
Standard Deviation of Annual Returns
N/A
Max Drawdown -98%
Shares Statistics
Market Capitalization 252.3m USD
Shares Outstanding 104 355 000
Percentage of Shares Shorted 5.59%

ZY Return Decomposition
Main factors of price return

What is price return decomposition?

ZY News

Last Important Events
Zymergen Inc

Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.

All
Positive
Negative

Sentiment Analysis
Zymergen Inc

Today
Last 7 Days 7D
Last 30 Days 30D
Last 90 Days 90D

Company Profile

Zymergen Inc

Country

United States of America

Industry

Chemicals

Market Cap

252.3m USD

Dividend Yield

0%

Description

Zymergen, Inc. engages in the design, development, and commercialization of bio-based products. The company is headquartered in Emeryville, California and currently employs 507 full-time employees. The company went IPO on 2021-04-22. Its platform consists of three key capabilities: its collection of accessible biomolecules; its software and data science technology, and its data-driven microbe optimization processes. Its businesses include advanced materials, which seeks to employ bio-advantaged molecules or microbes to develop and deliver products and is focused on four markets: agriculture, water repellency, advanced polymers, and healthcare; drug discovery business leverages its differentiated access to natural products as a source of diverse chemical matter provided by its unified metagenomics database, and automation business, which offers automation technology to organizations involved in lab operations. Its software and data science platform informs, guides, and records its experiments forming the infrastructure for the learning cycle.

Contact

CALIFORNIA
Emeryville
5980 Horton Street, Suite 105
+14158018073.0
https://zymergen.com/

IPO

2021-04-22

Employees

507

Officers

Chief Financial Officer
Ms. Enakshi Singh
Chief Technology Officer
Mr. Dmitriy Ryaboy
Director of Communications
Mike Dulin
Chief Commercial Officer
Mr. Lincoln Germain
Chief Devel. Officer
Mr. Subodh S. Deshmukh
Sr. VP of Drug Discovery
Mr. Devin Scannell
Show More
Sec.
Mr. Duane Valz J.D.
Corp. Sec.
Ms. Mina Kim
Show Less

See Also

Discover More